News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Joshua Richter: Amazing Paper on Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
Photo of Joshua Richter from medicalnewstoday.com
Jun 23, 2024, 19:16

Joshua Richter: Amazing Paper on Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology at The Tisch Cancer Institute, shared on X/Twitter:

“Honored to by co-lead author with Naresh Bumma on this amazing paper: Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma | Journal of Clinical Oncology.”

Joshua Richter

Visit the article site.
Source: Joshua Richter/X

Anasuya Hazra Anita Boyapati Attaya Suvannasankha cancer Chang-Ki Min Dhruti Chokshi George D. Yancopoulos Glenn S. Kroog Hans C. Lee Hematology Ja Min Byun James E. Hoffman Jeffrey A. Zonder Jing Christine Ye Joaquín Martínez-Lopez Joseph J. Maly Joshua Richter Journal of Clinical Oncology Ka Lung Wu Kaniel Cassady Karen Rodriguez Lorenc L. Andres Sirulnik Linvoseltamab Madhav V. Dhodapkar Mansi R. Shah Marie-Christiane Vekemans Markus Munder Matthew J. Pianko Michelle DeVeaux Naresh Bumma OncoDaily Oncology Rachid Baz Rebecca Silbermann relapsed/refractory multiple myeloma Sundar Jagannath Suzanne Lentzsch Swathi Namburi Yariv Houvras
Special Coverage
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public
Blog
Dec 22, 2024, 04:34
Nermean Mostafa: Honored to co-organize women cancer patient advocacy session hosted by 8th Gyne-Oncology conference
Blog
Dec 22, 2024, 04:24
Jordan Rathkopf: As 2024 winds down, we’ve been reflecting on what a year it’s been
Insight
Dec 22, 2024, 00:21
Eric J. Small: ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed
Blog
Dec 21, 2024, 22:40
50 Years of History, a Future to Write Together - AIEOP
Science
Dec 21, 2024, 22:37
Breaking Down the Impact of Ionizing Radiation on Cancer
Blog
Dec 21, 2024, 22:35
Santiago Viteri: Latest findings from the BR.31 trial presented at the 2024 ESMO Congress